Pharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non–Small Cell Lung Cancer
暂无分享,去创建一个
Andreas Rimner | Heiko Schöder | Jazmin Schwartz | Milan Grkovski | Pat B Zanzonico | John L Humm | S. Nehmeh | J. Humm | A. Rimner | H. Schöder | P. Zanzonico | Kevin D Staton | S. Carlin | M. Grkovski | Sean D Carlin | Sadek A Nehmeh | J. Schwartz
[1] Tom W J Scheenen,et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. , 2006, International journal of radiation oncology, biology, physics.
[2] S. Nehmeh,et al. Feasibility of 18F-Fluoromisonidazole Kinetic Modeling in Head and Neck Cancer Using Shortened Acquisition Times , 2016, The Journal of Nuclear Medicine.
[3] M. Graham,et al. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. , 1995, Medical physics.
[4] Barbara Vanderstraeten,et al. Positron emission tomography-guided, focal-dose escalation using intensity-modulated radiotherapy for head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[5] K. Krohn,et al. Synthesis and characterization of congeners of misonidazole for imaging hypoxia. , 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[6] E. Milne. Circulation of primary and metastatic pulmonary neoplasms. A postmortem microarteriographic study. , 1967, The American journal of roentgenology, radium therapy, and nuclear medicine.
[7] F J Gilbert,et al. Imaging tumour hypoxia with positron emission tomography , 2014, British Journal of Cancer.
[8] Robert Tibshirani,et al. An Evaluation of Tumor Oxygenation and Gene Expression in Patients with Early Stage Non–Small Cell Lung Cancers , 2006, Clinical Cancer Research.
[9] Matthias Reimold,et al. Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Andrew Jackson,et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[11] S. Ametamey,et al. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] A. Heerschap,et al. Hypoxia in relation to vasculature and proliferation in liver metastases in patients with colorectal cancer. , 2006, International journal of radiation oncology, biology, physics.
[13] Brian F. Hutton,et al. The importance of correction for tissue fraction effects in lung PET: preliminary findings , 2011, European Journal of Nuclear Medicine and Molecular Imaging.
[14] David L. Schwartz,et al. Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer , 2006, Clinical Cancer Research.
[15] K. Krohn,et al. Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells. , 1987, Radiation research.
[16] M. Muzi,et al. Imaging Hypoxia with 18F-Fluoromisonidazole: Challenges in Moving to a More Complicated Analysis , 2016, The Journal of Nuclear Medicine.
[17] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[18] A H Baydush,et al. Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions. , 2004, Medical physics.
[19] C. Ling,et al. New radiotherapy technologies. , 2003, Seminars in surgical oncology.
[20] J. Eary,et al. [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[21] Sadek Nehmeh,et al. Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[22] K L Lindsley,et al. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. , 1995, International journal of radiation oncology, biology, physics.
[23] John L. Humm,et al. Evaluation of a compartmental model for estimating tumor hypoxia via FMISO dynamic PET imaging , 2008, Physics in medicine and biology.
[24] A. Sweet-Cordero,et al. Hypoxia in Models of Lung Cancer: Implications for Targeted Therapeutics , 2010, Clinical Cancer Research.
[25] J. D. Chapman,et al. A marker for hypoxic cells in tumours with potential clinical applicability. , 1981, British Journal of Cancer.
[26] B. Hutton,et al. Improved correction for the tissue fraction effect in lung PET/CT imaging. , 2015, Physics in medicine and biology.
[27] A. A. Lammertsma,et al. On the use of image-derived input functions in oncological fluorine-18 fluorodeoxyglucose positron emission tomography studies , 1999, European Journal of Nuclear Medicine.
[28] A. Kjaer,et al. Kinetic modeling in PET imaging of hypoxia. , 2014, American journal of nuclear medicine and molecular imaging.
[29] John L. Humm,et al. Pharmacokinetic Analysis of Hypoxia 18F-Fluoromisonidazole Dynamic PET in Head and Neck Cancer , 2010, Journal of Nuclear Medicine.
[30] N. Gupta,et al. Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions. , 1998, Chest.
[31] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[32] Daniela Thorwarth,et al. A kinetic model for dynamic [18F]-Fmiso PET data to analyse tumour hypoxia , 2005, Physics in medicine and biology.
[33] H. Thierens,et al. [18F]fluoro-deoxy-glucose positron emission tomography ([18F]FDG-PET) voxel intensity-based intensity-modulated radiation therapy (IMRT) for head and neck cancer. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.